This paper describes the rationale followed for the integration of Dual-PECCS, a cognitively-inspired knowledge representation and reasoning system, into two rather different cognitive architectures, such as ACT-R and CLARION.
The rationale follows that pericytes perform a key biological role in providing survival factors for endothelial cells, and are critical for the overall integrity of the underlying vessels around which they are typically wrapped, and may be a source of mesenchymal stem cells [ 15, 24].
The rationale followed, the theoretical analysis performed and the confirmatory computational results found are summarized in this paper.
The rationale followed by these AQP techniques can be condensed into a three-phase procedure, called adaptivity loop [9].
The rationale followed here hinges on the coincidence of the failure modes of a stretching dominated lattice material, which experiences two types of microscopic failure modes, namely, elastic buckling and plastic yielding.
The rationale followed in control design consists in ensuring the achievement of a sliding motion which, in turn, guarantees the attraction of the state vector towards a boundary layer, whose maximum width depends on the uncertainty on output measurements caused by the presence of unknown deadzones in sensors.
The rationale followed was that PSI-BLAST should return all members of the given KOG within the first two iterations.
Following this rationale, it could be demonstrated that silicatein exists not only in the axial canal but also in the extraspicular and extracellular space (Müller et al. 2005; Schröder et al. 2006).
It is useful to dispose reliable prognostic factors in RCC for 3 major goals: providing patient information, designing rationale follow-up algorithms and selecting patients for adapted treatment schedules as well as new clinical trials.
It is useful to dispose reliable prognostic factors in Renal Cell Carcinoma (RCC) for 3 major goals: providing patient information, designing rationale follow-up algorithms and selecting patients for adapted treatment schedules as well as new clinical trials.
